Moors & Cabot’s Hologic HOLX Stock Holding History

Moors & Cabot’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,943	Closed	-$291K	–	932
2021 Q3	$291K	Buy	+3,943	New	+$296K	0.02%	610

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moors & Cabot's HOLX Position: Q4 2021 in Review

Moors & Cabot sold out of Hologic (HOLX) in Q4 2021, closing a stake of 3,943 shares — an estimated $291K sold.

Moors & Cabot first reported a position in HOLX in Q3 2021 and held it in 1 quarter. The position peaked at $291K in Q3 2021. 678 funds tracked by Wall St. Rank hold HOLX as of Q4 2021.

Moors & Cabot reported no remaining Hologic position as of Q4 2021 after selling out during the quarter.
Moors & Cabot sold 3,943 Hologic shares in Q4 2021, an estimated $291K.
Moors & Cabot first reported a position in Hologic in Q3 2021 and held it in 1 quarter.
Moors & Cabot's Hologic position peaked at $291K in Q3 2021.
678 funds tracked by Wall St. Rank held Hologic as of Q4 2021.

Based on Moors & Cabot's 13F filing for Q4 2021, filed 14 Feb 2022.